A Randomized Double-Masked Clinical Trial Comparing Four Periodontitis Treatment Strategies: 5-Year Tooth Loss Results

被引:13
|
作者
Preus, Hans R. [1 ]
Gjermo, Per [1 ]
Baelum, Vibeke [2 ]
机构
[1] Univ Oslo, Inst Clin Odontol, Dept Periodontol, Fac Dent, PO 1109 Blindern, N-0317 Oslo, Norway
[2] Aarhus Univ, Dept Dent Hlth, Aarhus, Denmark
关键词
Anti-bacterial agents; dental scaling; metronidazole; periodontal debridement; tooth extraction; tooth loss; LONG-TERM MAINTENANCE; TREATED PATIENTS; DISEASE PROGRESSION; SUPPORTIVE THERAPY; RISK-FACTOR; POPULATION; MORTALITY; CARE; DEFINITIONS; PARAMETERS;
D O I
10.1902/jop.2016.160332
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Tooth loss is the ultimate negative consequence of periodontitis, and reports of the extent to which different treatment strategies may influence long-term tooth loss are hard to find. This study aims to test the hypothesis that there is no difference in 5-year clinical outcome of therapy in terms of tooth mortality between groups of patients treated with conventional scaling and root planing (SRP) over weeks or same-day full-mouth disinfection (FDIS), with or without adjunctive metronidazole (MET). Methods: One hundred eighty-four patients with moderateto-severe periodontitis were randomly allocated to one of four treatment groups: 1) FDIS+ MET; 2) FDIS+ placebo; 3) SRP+MET; and 4) SRP+placebo. Total 161 patients (88%) completed the 5-year follow-up examination, and data on number and timing of tooth extractions as well as pre-extraction diagnoses and reasons for extractions were analyzed. Results: No differences were observed between groups with regard to number of, reasons for, or time of extractions in the four groups at baseline and 1, 3, and 5 years after treatment. Conclusion: If extraction or retention of teeth is regarded as a measure of failure or success 5 years after completion of periodontal therapy, none of the four strategies produced an end result better than the other. J Periodontol 2017; 88:144-152.
引用
收藏
页码:144 / 152
页数:9
相关论文
共 50 条
  • [21] Effect of Subcutaneous Lidocaine Infiltration on Blood Loss Secondary to Corporal Lipoaspiration: A Prospective, Randomized, Double-Masked Clinical Trial
    Llanos, Sergio
    Dagnino, Bruno
    Ponce, Daniel
    Bonacic, Sebastian
    Navarrete, Lindaura
    Navarrete, Sandra
    Mangelsdorff, Guenther
    Searle, Susana
    Mendez, Ignacio
    AESTHETIC PLASTIC SURGERY, 2009, 33 (05) : 738 - 742
  • [22] A RANDOMIZED, DOUBLE-MASKED, PLACEBO-CONTROLLED TRIAL OF CHLORTHALIDONE AND BONE LOSS IN ELDERLY WOMEN
    WASNICH, RD
    DAVIS, JW
    HE, YF
    PETROVICH, H
    ROSS, PD
    OSTEOPOROSIS INTERNATIONAL, 1995, 5 (04) : 247 - 251
  • [23] Are There Specific Benefits of Amoxicillin Plus Metronidazole in Aggregatibacter actinomycetemcomitans-Associated Periodontitis? Double-Masked, Randomized Clinical Trial of Efficacy and Safety
    Mombelli, Andrea
    Cionca, Norbert
    Almaghlouth, Adnan
    Decaillet, Fabien
    Courvoisier, Delphine S.
    Giannopoulou, Catherine
    JOURNAL OF PERIODONTOLOGY, 2013, 84 (06) : 715 - 724
  • [24] Local Drug Delivery of Alendronate Gel for the Treatment of Patients With Chronic Periodontitis With Diabetes Mellitus: A Double-Masked Controlled Clinical Trial
    Pradeep, A. R.
    Sharma, Anuj
    Rao, Nishanth S.
    Bajaj, Pavan
    Naik, Savitha B.
    Kumari, Mina
    JOURNAL OF PERIODONTOLOGY, 2012, 83 (10) : 1322 - 1328
  • [25] A double-masked, randomized, 1-year study comparing the corneal effects of dorzolamide, timolol, and betaxolol
    Lass, JH
    Khosrof, SA
    Laurence, JK
    Horwitz, B
    Ghosh, K
    Adamsons, I
    ARCHIVES OF OPHTHALMOLOGY, 1998, 116 (08) : 1003 - 1010
  • [26] Double-masked, randomized home-use clinical trial of a wearable collision warning device for the blind: preliminary results
    Pundlik, Shrinivas
    Baliutaviciute, Vilte
    Moharrer, Mojtaba
    Bowers, Alex R.
    Luo, Gang
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [27] High-Dosage Ascorbic Acid Treatment in Charcot-Marie-Tooth Disease Type 1A Results of a Randomized, Double-Masked, Controlled Trial
    Lewis, Richard A.
    McDermott, Michael P.
    Herrmann, David N.
    Hoke, Ahmet
    Clawson, Lora L.
    Siskind, Carly
    Feely, Shawna M. E.
    Miller, Lindsey J.
    Barohn, Richard J.
    Smith, Patricia
    Luebbe, Elizabeth
    Wu, Xingyao
    Shy, Michael E.
    JAMA NEUROLOGY, 2013, 70 (08) : 981 - 987
  • [28] BRAzil magnesium (BRAMAG) trial: a double-masked randomized clinical trial of oral magnesium supplementation in pregnancy
    Carla Adriane Leal de Araújo
    Joel Geoffrey Ray
    José Natal Figueiroa
    João Guilherme Alves
    BMC Pregnancy and Childbirth, 20
  • [29] Functional Lung Avoidance for Individualized Radiation Therapy: Results of a Double-Masked, Randomized Controlled Trial
    Yaremko, Brian P.
    Capaldi, Dante P., I
    Sheikh, Khadija
    Palma, David A.
    Warner, Andrew
    Dar, A. Rashid
    Yu, Edward
    Rodrigues, George B.
    Louie, Alexander, V
    Landis, Mark
    Sanatani, Michael
    Vincent, Mark D.
    Younus, Jawaid
    Kuruvilla, Sara
    Chen, Jeff Z.
    Erickson, Abigail
    Gaede, Stewart
    Parraga, Grace
    Hoover, Douglas A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 113 (05): : 1072 - 1084
  • [30] BRAzil magnesium (BRAMAG) trial: a double-masked randomized clinical trial of oral magnesium supplementation in pregnancy
    de Araujo, Carla Adriane Leal
    Ray, Joel Geoffrey
    Figueiroa, Jose Natal
    Alves, Joao Guilherme
    BMC PREGNANCY AND CHILDBIRTH, 2020, 20 (01)